CI Form 4: Director Elects $300.87‑Priced Phantom Stock Deferral
Rhea-AI Filing Summary
Kurian George, a director of The Cigna Group (CI), reported a compensation deferral into the company’s deferred compensation plan on 08/29/2025. The filing shows an acquisition of 99.7109 phantom stock units under the Deferral Plan at a recorded price of $300.87 per unit; each phantom unit is economically equivalent to one share of Cigna common stock and will be settled in cash. After the transaction the report shows 1,574.5491 shares (or phantom-equivalent units) beneficially owned by the reporting person, which includes 7.0495 units received via dividend reinvestment. The Form 4 was filed by one reporting person and signed by an attorney-in-fact on 09/02/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine director compensation deferral into a phantom stock plan; aligns director economics with shareholder performance but is not a cash-equity purchase.
The filing documents a voluntary election by Director Kurian George to defer cash retainer into the Deferral Plan via phantom stock units that are cash-settled. Such deferrals are common governance practices to align board interests with shareholder value without issuing actual shares or affecting share count. The transaction increases the director's economic exposure to Cigna's stock performance while preserving the company’s outstanding share count because settlement is in cash. The inclusion of 7.0495 units from dividend reinvestment is an administrative detail and does not indicate an additional cash outlay by the director.
TL;DR: Compensation deferral into phantom units recorded; impact on company finances is limited and primarily affects future cash settlement obligations.
From a pay-structure perspective, deferring cash into a hypothetical stock fund converts immediate cash compensation into a contingent cash liability tied to equity value. The filing reports 99.7109 units acquired at a unit value of $300.87, implying the deferral amount recorded. Because phantom units settle in cash, this creates a future cash obligation rather than immediate dilution. For investors assessing liquidity or long-term cash obligations, the filing signals a modest future cash settlement exposure tied to director pay but provides no material change to operations or capital structure.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Phantom Stock Units | 99.711 | $300.87 | $30K |
Footnotes (1)
- Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash. Includes 7.0495 phantom stock units acquired pursuant to a dividend reinvestment feature of the Deferral Plan.
